Literature DB >> 2935496

Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Altered activity in essential hypertension.

T J Resink, V A Tkachuk, P Erne, F R Bühler.   

Abstract

Platelet free Ca2+ concentration has been found to be elevated in essential hypertension and to correlate with blood pressure level. Free cytoplasmic calcium concentration is determined by calcium influx, pooling, and efflux. The present study found a Ca2+-ATPase in platelet membranes that has a high affinity for Ca2+ (Km approximately 1 microM), is inhibited by low concentrations of orthovanadate (Ki approximately 1 microM), and can be stimulated by calmodulin (Km approximately 5 nM). The absolute increase in calmodulin-stimulated Ca2+-ATPase activity was not different between normotensive and hypertensive subjects; however, the degree of stimulation of Ca2+-ATPase activity at saturating calmodulin concentrations apparently was diminished in calmodulin-deficient membranes from subjects with established essential hypertension (40%) as compared to that in normotensive subjects of similar age (135%; p less than 0.001). Affinities for calmodulin and Ca2+ were comparable between the two groups, while the capacity for Ca2+-ATPase activity (basal and calmodulin-stimulated) was markedly greater (1.5- to 1.8-fold) in both native and calmodulin-deficient membranes from hypertensive subjects. On the other hand, the defective calcium efflux pump activity, as assessed by a decreased degree of calmodulin stimulation, may have contributed to elevated cytoplasmic calcium concentrations and the associated enhanced hormone sensitivity in platelets from essential hypertensive subjects. This may represent an adaptive negative feedback control mechanism to protect the cell against Ca2+ overload.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2935496     DOI: 10.1161/01.hyp.8.2.159

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  Antihypertensive treatment according to age, plasma renin and race.

Authors:  F R Bühler
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

2.  Correlation of blood pressure in end-stage renal disease with platelet cytosolic free-calcium concentration.

Authors:  H Schiffl
Journal:  Klin Wochenschr       Date:  1990-07-17

3.  Platelet calcium pump activity in essential hypertensives and their first-degree relatives.

Authors:  S Gulati; M Khullar; B K Sharma; N K Ganguly
Journal:  Mol Cell Biochem       Date:  1996-03-09       Impact factor: 3.396

4.  Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells.

Authors:  F Saito; M T Hori; M Fittingoff; T Hino; M L Tuck
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 5.  Alterations in sodium metabolism as an etiological model for hypertension.

Authors:  P Lijnen
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

6.  Abnormality of calmodulin activity in hypertension. Evidence of the presence of an activator.

Authors:  S L Huang; Y I Wen; D B Kupranycz; S C Pang; G Schlager; P Hamet; J Tremblay
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

Review 7.  Platelet abnormalities and the pathophysiology of essential hypertension.

Authors:  F R Bühler; T J Resink
Journal:  Experientia       Date:  1988-02-15

8.  Spontaneously hypertensive rats and platelet Ca(2+)-ATPases: specific up-regulation of the 97 kDa isoform.

Authors:  B Papp; E Corvazier; C Magnier; T Kovàcs; N Bourdeau; S Lévy-Tolédano; R Bredoux; B Lévy; P Poitevin; A M Lompré
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

9.  Calcium pump of the plasma membrane is localized in caveolae.

Authors:  T Fujimoto
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.